American Century Companies INC Has Increased Medtronic Plc (MDT) Holding by $181.29 Million as Stock Rose

February 25, 2018 - By Richard Conner

Investors sentiment increased to 1.12 in 2017 Q3. Its up 0.22, from 0.9 in 2017Q2. It improved, as 73 investors sold MDT shares while 392 reduced holdings. 109 funds opened positions while 414 raised stakes. 1.07 billion shares or 1.07% more from 1.06 billion shares in 2017Q2 were reported. Valicenti Advisory Services invested in 66,441 shares. South Dakota Inv Council holds 661,621 shares or 1.04% of its portfolio. Bedrijfstakpensioenfonds Voor De Media Pno stated it has 45,679 shares or 0.4% of all its holdings. Carnegie Cap Asset Mngmt Limited Com holds 0.1% of its portfolio in Medtronic plc (NYSE:MDT) for 10,938 shares. Stonebridge Advisors Llc holds 8,044 shares. Macquarie Group Inc Ltd invested 0.06% of its portfolio in Medtronic plc (NYSE:MDT). Garrison Finance invested in 1.67% or 38,208 shares. First Republic Invest Management has 0.34% invested in Medtronic plc (NYSE:MDT) for 614,744 shares. Mirae Asset Invs Commerce Limited holds 72,572 shares or 0.1% of its portfolio. Choate Invest invested in 0.05% or 11,279 shares. Amica Pension Fund Board Of Trustees holds 0.59% or 63,605 shares in its portfolio. Flossbach Von Storch Ag holds 2.37 million shares or 1.93% of its portfolio. Qs Invsts Lc has invested 0.05% in Medtronic plc (NYSE:MDT). Fernwood Inv Mngmt Ltd Liability Com reported 18,573 shares. Etrade Cap Mngmt Limited Liability Corporation holds 52,504 shares.

American Century Companies Inc increased its stake in Medtronic Plc (MDT) by 35% based on its latest 2017Q3 regulatory filing with the SEC. American Century Companies Inc bought 2.35M shares as the company’s stock rose 5.51% with the market. The institutional investor held 9.08M shares of the electromedical & electrotherapeutic apparatus company at the end of 2017Q3, valued at $706.34 million, up from 6.73 million at the end of the previous reported quarter. American Century Companies Inc who had been investing in Medtronic Plc for a number of months, seems to be bullish on the $108.95B market cap company. The stock decreased 0.02% or $0.02 during the last trading session, reaching $80.39. About 5.17 million shares traded. Medtronic plc (NYSE:MDT) has risen 4.04% since February 25, 2017 and is uptrending. It has underperformed by 12.66% the S&P500.

American Century Companies Inc, which manages about $98.84B US Long portfolio, decreased its stake in Accenture Plc Ireland (NYSE:ACN) by 23,072 shares to 29,869 shares, valued at $4.03M in 2017Q3, according to the filing. It also reduced its holding in Amgen Inc (NASDAQ:AMGN) by 465,294 shares in the quarter, leaving it with 1.28M shares, and cut its stake in Edison Intl (NYSE:EIX).

More recent Medtronic plc (NYSE:MDT) news were published by: which released: “Medtronic Completes Covidien Acquisition for $50B – Analyst Blog” on January 27, 2015. Also published the news titled: “3 Big Stock Charts for Tuesday: Hershey Co (HSY), Juniper Networks, Inc. (JNPR …” on September 05, 2017.‘s news article titled: “3 Big Stock Charts for Monday: Activision Blizzard, Inc. (ATVI), Netflix, Inc …” with publication date: October 09, 2017 was also an interesting one.

Medtronic plc (NYSE:MDT) Ratings Coverage

Among 28 analysts covering Medtronic (NYSE:MDT), 18 have Buy rating, 0 Sell and 10 Hold. Therefore 64% are positive. Medtronic had 81 analyst reports since August 10, 2015 according to SRatingsIntel. UBS maintained the shares of MDT in report on Friday, February 17 with “Buy” rating. Guggenheim initiated the stock with “Neutral” rating in Thursday, June 9 report. As per Monday, July 31, the company rating was maintained by Deutsche Bank. The stock of Medtronic plc (NYSE:MDT) has “Buy” rating given on Wednesday, August 23 by Needham. Needham maintained Medtronic plc (NYSE:MDT) rating on Wednesday, November 23. Needham has “Buy” rating and $84 target. As per Tuesday, July 18, the company rating was maintained by Oppenheimer. The firm earned “Neutral” rating on Tuesday, January 3 by Bank of America. RBC Capital Markets maintained the shares of MDT in report on Tuesday, September 29 with “Outperform” rating. On Monday, June 26 the stock rating was maintained by Oppenheimer with “Buy”. Needham maintained it with “Buy” rating and $95.0 target in Tuesday, September 5 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.